Joint Effect of MCP-1 Genotype GG and MMP-1 Genotype 2G/2G Increases the Likelihood of Developing Pulmonary Tuberculosis in BCG-Vaccinated Individuals
Open Access
- 25 January 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (1), e8881
- https://doi.org/10.1371/journal.pone.0008881
Abstract
We previously reported that the – 2518 MCP-1 genotype GG increases the likelihood of developing tuberculosis (TB) in non-BCG-vaccinated Mexicans and Koreans. Here, we tested the hypothesis that this genotype, alone or together with the – 1607 MMP-1 functional polymorphism, increases the likelihood of developing TB in BCG-vaccinated individuals. We conducted population-based case-control studies of BCG-vaccinated individuals in Mexico and Peru that included 193 TB cases and 243 healthy tuberculin-positive controls from Mexico and 701 TB cases and 796 controls from Peru. We also performed immunohistochemistry (IHC) analysis of lymph nodes from carriers of relevant two-locus genotypes and in vitro studies to determine how these variants may operate to increase the risk of developing active disease. We report that a joint effect between the – 2518 MCP-1 genotype GG and the – 1607 MMP-1 genotype 2G/2G consistently increases the odds of developing TB 3.59-fold in Mexicans and 3.9-fold in Peruvians. IHC analysis of lymph nodes indicated that carriers of the two-locus genotype MCP-1 GG MMP-1 2G/2G express the highest levels of both MCP-1 and MMP-1. Carriers of these susceptibility genotypes might be at increased risk of developing TB because they produce high levels of MCP-1, which enhances the induction of MMP-1 production by M. tuberculosis-sonicate antigens to higher levels than in carriers of the other two-locus MCP-1 MMP-1 genotypes studied. This notion was supported by in vitro experiments and luciferase based promoter activity assay. MMP-1 may destabilize granuloma formation and promote tissue damage and disease progression early in the infection. Our findings may foster the development of new and personalized therapeutic approaches targeting MCP-1 and/or MMP-1.Keywords
This publication has 53 references indexed in Scilit:
- Drivers of tuberculosis epidemics: The role of risk factors and social determinantsSocial Science & Medicine, 2009
- The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous InfectionCell, 2009
- Genome Scan of M. tuberculosis Infection and Disease in UgandansPLOS ONE, 2008
- MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West AfricaHuman Molecular Genetics, 2008
- Interfering with extracellular matrix degradation to blunt inflammationCurrent Opinion in Pharmacology, 2008
- PCA-Correlated SNPs for Structure Identification in Worldwide Human PopulationsPLoS Genetics, 2007
- Unique Gene Expression Profiles in Infants Vaccinated with Different Strains ofMycobacterium bovisBacille Calmette-GuérinInfection and Immunity, 2007
- Malnutrition and Infection: Complex Mechanisms and Global ImpactsPLoS Medicine, 2007
- Genome plasticity of BCG and impact on vaccine efficacyProceedings of the National Academy of Sciences, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001